Corresponding author: Hye Soon Kim http://orcid.org/0000-0001-6298-3506 Division of Endocrinology and Metabolism, Department of Internal Medicine, Keimyung University School of Medicine, 56, Dalseong-ro, Jung-gu, Daegu 41931, Korea E-mail: hsk12@dsmc.or.kr In 2002, the National Academy of Clinical Biochemistry (NACB) published “Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus” [1]. Measurement of plasma glucose was the only diagnostic criterion for diabetes. Glycemic control was monitored by measuring glucose using patients’ plasma or blood glucose with meters and laboratory analysis of glycosylated hemoglobin (HbA1c). Ten years later, these recommendations were updated by a multidisciplinary guideline team including clinical, laboratory, and evidence-based guideline methodology experts [2]. The guidelines were reviewed by the joint evidencebased Laboratory Medicine Committee of the American Association for Clinical Chemistry and the NACB, and the guidelines were accepted after revision by the Professional Practice Committee and approved by the Executive Committee of the American Diabetes Association (ADA). In addition to measurement of venous plasma glucose, HbA1c concentration in blood can also be used for the diagnosis of diabetes mellitus. When glucose is used to diagnose diabetes, the guideline recommends it to be measured in venous plasma in an accredited laboratory. Sample tube should be placed immediately in an ice-water slurry to minimize glycolysis, and the plasma should be separated from the cells within 30 minutes, otherwise a tube containing a rapidly effective glycolysis inhibitor like citrate buffer should be used. Samples for fasting plasma glucose (FPG) analysis should be drawn in the morning rather than in the daytime because of diurnal variation in FPG, which is higher in the morning than in the afternoon [3]. The concentration of glucose decreases due to glycolysis by erythrocyte, white blood cells, and platelet, which degrades glucose at a rate of 5% to 7% per hour [4]. On occasion, it needs to be transported from the site where it was sampled to a remote laboratory facility for glucose measurement, due to which the blood glucose values can appear to be lower than the actual value and lead to false diagnosis, especially for those who are near the cut-off value. The method used for blood processing can also influence blood glucose levels. Plasma glucose values are about 11% higher than those of whole blood when the hematocrit is normal. Postprandial capillary blood glucose levels are higher than venous blood glucose levels by up to 20%, probably due to glucose consumption in tissues [5]. With regards to the differences in blood glucose level between plasma and serum, some studies reported that plasma glucose is higher than serum glucose whereas other studies found no difference. Nonetheless, measurement of glucose in serum is not recommended for the diagnosis of diabetes [6,7], while plasma allows samples to be centrifuged promptly without waiting for the blood to clot. In this regards, Kang et al. [8] attempted to compare fasting serum glucose with FPG in real-life clinical situations and also examined an ordinary time delay in sample processing for a month. Serum samples were centrifuged within 1 hour and glucose was measured within 2 hours, while plasma samples were immediately centrifuged and glucose was measured within 15 minutes. Among 1,254 participants, mean glucose concentrations for plasma and serum were 119.4±9.9 and Editorial Others
[1]
U. Larsson‐cohn,et al.
Differences between capillary and venous blood glucose during oral glucose tolerance tests.
,
1976,
Scandinavian journal of clinical and laboratory investigation.
[2]
R. Swaminathan,et al.
Effectiveness of sodium fluoride as a preservative of glucose in blood.
,
1989,
Clinical chemistry.
[3]
R. Troisi,et al.
Diurnal variation in fasting plasma glucose: implications for diagnosis of diabetes in patients examined in the afternoon.
,
2000,
JAMA.
[4]
Y. Jang,et al.
Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease
,
2010
.
[5]
V. Basevi.
Standards of Medical Care in Diabetes—2010
,
2010,
Diabetes Care.
[6]
Å. Lernmark,et al.
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
,
2002,
Diabetes Care.
[7]
S. Ihm,et al.
A Potential Issue with Screening Prediabetes or Diabetes Using Serum Glucose: A Delay in Diagnosis
,
2016,
Diabetes & metabolism journal.